Finally: War On Medical Marijuana Ends As Feds Lift The

New Post Public Reply Private Reply Replies (1) Message Board
Jerseyfish
373
Finally: War On Medical Marijuana Ends As Feds Lift The Ban
By
admin -
December 24, 2017

Eighty-five years ago marijuana was banned by federal statute and in the 1970’s marijuana was classified by the federal government as a controlled substance – drugs designated illegal, which could only be illicitly obtained. These drugs were often demonized as habit-forming associated with less desirable folks with addiction issues – not contributing to society – and the focus of the morally misguided failed federal ‘War on Drugs’. Interestingly, in 2013 according to a Gallup poll, for the first time some 58% of citizens supported legalization, yet marijuana is still on the federal controlled substance list alongside dangerous drugs such as heroin and meth. However, the use of medical marijuana has been approved by 23 states and the District of Columbia to help minimize the side-effects of diseases ranging from nausea and glaucoma to cancer and HIV/AIDS; used to treat ailments like multiple sclerosis and to help with chronic pain – but it was still banned on the federal leveluntil a provision that lifted the ban was “quietly placed in the recent spending bill” passed by Congress last week.

Despite the legalization of medical marijuana in these states and recent studies showing that it is not a gate-way drug – a drug the use of which leads to the use of other more addicting drugs – the federal government had retained the right to raid and harass medical marijuana dispensaries and prosecute their owners. This new legislation is a turning point in how the federal government views medical marijuanaand it had vigorous bi-partisan support.

Representative Dana Rohrabacher (R-CA), one of the bill’s co-authors commented:

“This is a victory for so many. The first time in decades that the federal government has curtailed its oppressive prohibition of marijuana”

On this historic move by Congress, Representative Sam Farr (D-CA) said:

“The federal government will finally respect the decisions made by the majority of states that passed medical marijuana laws. This is a great day for common sense because now our federal dollars will be spent more wisely on prosecuting criminals and not sick patients.”

This is a huge deal because up and until recently, Republicans have long been against any type of marijuana legalized, while Democrats have been in favor of relaxing the law. Fortunately, enough Republicans voted for the bill. Some have argued that the Republican change of heart is motivated by trying to lure the millennial demographic, “since the legalization of marijuana is a big issue with the millennials, So Republicans are now starting to ease up on their anti-marijuana rhetoric.”

It is also legal to fully purchase marijuana in four states for reasons other than medicinal use, but its full legalization is still prohibited by federal law. Bernie Sanders, who had sponsored legislation supporting states’ rights to legalize marijuana for medical use more than a decade ago, became the first candidate to endorse the full legalization of pot during the Democratic debate in October. Sanders rightfully seesour criminal justice system destroying too many lives by disproportionately mistreating non-violent drug offenders:

“I am seeing in this country too many lives being destroyed for non-violent offenses. We have a criminal justice system that lets CEOs on Wall Street walk away, and yet we are imprisoning or giving jail sentences to young people who are smoking marijuana. I think we have to think through this war on drugs…which has done an enormous amount of damage. We need to rethink our criminal justice system, we we’ve got a lot of work to do in that area.”

This is no doubt a turning point in legally allowing the use of pot to help people with legitimate medical needs for which the use of medicinal marijuana has been shown to provide relief. Perhaps, with the public in favor of full legalization of pot and politicians starting recognize how insidious it is to incarcerate non-violent drug offenders – principally people of color and minorities – full legalization is just around the corner.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 5

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading

Top 5 Most Recently Viewed Articles

Justin Thompson Takes Charge as VP of IT Data and Analytics

Updated Category News Views 486

JetBlue's New Leadership in Data and Analytics JetBlue has announced a significant promotion within its ranks by naming Justin Thompson as Vice President of IT Data and Analytics. This strategic appointment highlights JetBlue's commitment to leveraging data as a core component of its operational and growth strategies. Role and Responsibilities of Justin Thompson In his...

Continue Reading
Navigating Growth in the Ultrafine Pulverizer Market Landscape

Updated Category News Views 153

Understanding the Ultrafine Pulverizer Market The global ultrafine pulverizer market is currently valued at approximately USD 1.2 billion, with immense growth predicted over the next decade. As we look ahead to the year 2034, the market is anticipated to swell to USD 2.5 billion, exhibiting a robust Compound Annual Growth Rate (CAGR) of about 7.6% from 2025 to 2034. This...

Continue Reading
Fosun's Commitment to Global Health Through Innovation

Updated Category News Views 181

Fosun's Global Innovation Strategy Guo Guangchang, Chairman of Fosun International, has recently emphasized the importance of globalization and innovation at a biopharmaceutical conference. Underlining that the future of the pharmaceutical industry lies in original innovation and open cooperation, he reinforced Fosun's commitment to integrating global advancement...

Continue Reading
Investors Beware: Is Beta Bionics (NASDAQ: BBNX) in Trouble?

Updated Category News Views 305

The Deep Dive into Beta Bionics (NASDAQ: BBNX) Here we are again, folks. Hearing rumblings about Beta Bionics, and I can't help but feel a slight knot in my stomach. Just when you think the market's gotta settle down, it throws a curveball, and right now, it looks like Beta Bionics is in murky waters courtesy of potential legal troubles. I mean, when litigation starts...

Continue Reading
Noah Holdings Reports Strong Q1 2025 Earnings and Growth Trends

Updated Category News Views 161

Noah Holdings Reports Strong Q1 2025 Earnings and Growth Trends Noah Holdings Limited (NYSE: NOAH), a prominent player in wealth management services, reported impressive financial results for the first quarter of 2025, demonstrating notable year-on-year (YoY) and sequential growth in profitability. The company, known for its tailored advisory services aimed at...

Continue Reading